Growth Metrics

OmniAb (OABI) Common Equity (2021 - 2026)

OmniAb (OABI) reported Common Equity of $262.6 million for Q1 2026, down 3.97% year-over-year from $273.5 million in Q1 2025, and down 1.64% on a QoQ basis from $267.0 million in Q4 2025.

OmniAb (OABI) has 6 years of Common Equity data on file, last reported at $262.6 million in Q1 2026.

  • Quarterly Common Equity fell 3.97% year-over-year to $262.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $262.6 million (down 3.97% YoY) and the FY2025 annual result came in at $267.0 million, down 7.16% from the prior year.
  • Common Equity slipped to $262.6 million in Q1 2026 per OABI's latest filing, from $267.0 million in the prior quarter.
  • Across five years, Common Equity topped out at $341.4 million in Q4 2022 and bottomed at $224.9 million in Q1 2022.
  • The 5-year median for Common Equity is $287.6 million (2024), against an average of $285.7 million.
  • The widest annual swing landed in 2022, when Common Equity jumped 1509933.93%; it then decreased 11.87% in 2024.
  • Tracing OABI's Common Equity over 5 years: stood at $341.4 million in 2022, then retreated by 7.85% to $314.6 million in 2023, then dropped by 8.57% to $287.6 million in 2024, then retreated by 7.16% to $267.0 million in 2025, then declined by 1.64% to $262.6 million in 2026.
  • Per Business Quant, the three latest OABI Common Equity figures stand at $262.6 million (Q1 2026), $267.0 million (Q4 2025), and $277.4 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -1.42 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 35.63 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 1.00 Bn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 14.38 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 19.36 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - 13.21 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 31.42 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.08 Bn
10 OmniAb 334.72 Mn 291.75 Mn 14.41 Mn 262.65 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 262.65 Mn
Dec 31, 2025 267.03 Mn
Sep 30, 2025 277.44 Mn
Jun 30, 2025 262.06 Mn
Mar 31, 2025 273.52 Mn
Dec 31, 2024 287.62 Mn
Sep 30, 2024 291.73 Mn
Jun 30, 2024 294.18 Mn
Mar 31, 2024 301.39 Mn
Dec 31, 2023 314.59 Mn
Sep 30, 2023 324.55 Mn
Jun 30, 2023 333.81 Mn
Mar 31, 2023 340.80 Mn
Dec 31, 2022 341.37 Mn
Sep 30, 2022 232.71 Mn
Jun 30, 2022 226.94 Mn
Mar 31, 2022 224.92 Mn
Dec 31, 2021 234.31 Mn
Sep 30, 2021 -6.90 Mn
Jun 30, 2021 15,029.00
Mar 31, 2021 17,214.00